News

Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.
Adverse reactions to weight-loss jabs are set to soar by more than 350% in a single year, according to the latest data.
We expected miracles; what we got was a legal minefield. As GLP-1 drugs like Ozempic reshape bodies and bottom lines, a ...
Ozempic, Wegovy and Mounjaro can still be expensive, but pharmacy produced GLP-1 compounds are becoming much more affordable.
People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.
A doctor has issued an warning as to why Ozempic shouldn't be used for weight loss as it does one alarming thing to body.
Following a similar decision in case the trade group Outsourcing Facilities Association brought against FDA over its decision ...
It was spurred by the Intercept’s disclosure of Musk’s hitherto-secret White House email address: [email protected]. When the Intercept first published Musk’s email address, on March 6, journalist ...
A new federal ruling means that patients will no longer have access to cheaper versions of Eli Lilly weight loss and diabetes ...
Weight loss drugs are getting more popular, even for teenagers and pre-teens -- but while many doctors have reported ...
Investors are worried Novo Nordisk's competition with Eli Lilly is heating up and that the first-to-market GLP-1 leader is ...
CEO Tara Comonte said the weight-loss program has no plans to shut down, and that its 3.4 million members would not be ...